The market for drugs that fight cancer by focusing on specific molecules, proteins and enzymes...
The Food and Drug Administration has declined to approve a drug used to treat restless...
Some investors quoted in published reports foresee huge gains for such retail pharmacy chains as...
The Food and Drug Administration has approved a generic hypertension drug made by India-based Lupin...
Patent expiries on blockbuster branded drugs could mean huge profits for some retail pharmacy chains,...
Pfizer had some impressive results in the earnings report it released Wednesday, but the company...
A drug from Boehringer Ingelheim and Pfizer will retain Decision Resources’ status as a gold...
A topical treatment for post-herpetic neuralgia, more commonly known as shingles, has received an orphan...
Pfizer’s acquisition of Wyeth appears to be paying off for the world’s largest drug maker....
A hypothetical fibromyalgia drug that improved sleeping quality better than the top-selling drugs on the...
Two drug companies are in a race to buy a German generic drug maker, according...
Data from a recent review of a treatment for chronic obstructive pulmonary disease do not...
Two drug makers have entered an agreement to develop a drug designed to treat melanoma....
A new study found that a nonsteroidal anti-inflammatory drug may reduce a patient's risk of...
The National Association of Chain Drug Stores will host two webinars in January in an...
This is further substantiation that the business of over-the-counter medicines, particularly those sold in the...
What’s really intriguing behind the return of a consumer division to Pfizer is the fact...
Johnson & Johnson’s Bengay PM product ought to spice up arthritis relievers on two accounts...
Support for a regulatory pathway for biosimilars has grown rapidly, and even a few branded...
The last few weeks have seen a lot of acquisition activity among large pharmaceutical companies....
The deal gives a great deal of added heft to Pfizer’s pharmaceutical division — the...